New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Industry

CPC
C12N2710/24222

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Recombinant Orf virus vector
- Patent number 11,286,500
- Issue date Mar 29, 2022
- Eberhard Karls Universitat Tubingen Medizinische Fakultat
- Hanns-Joachim Rziha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treatment using oncolytic viruses
- Patent number 10,967,015
- Issue date Apr 6, 2021
- New York University
- Ian J Mohr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant proteins of parapdxvirus ovis and pharmaceutical compos...
- Patent number 9,714,272
- Issue date Jul 25, 2017
- AiCuris GmbH & Co. KG
- Olaf Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant proteins of Parapoxvirus ovis and pharmaceutical compos...
- Patent number 8,852,577
- Issue date Oct 7, 2014
- AiCuris GmbH & Co. KG
- Olaf Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant proteins of parapoxvirus ovis and pharmaceutical compos...
- Patent number 8,357,363
- Issue date Jan 22, 2013
- AiCuris GmbH & Co. KG
- Olaf Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of Parapox B2L protein to treat cancer and modify immune responses
- Patent number 6,844,000
- Issue date Jan 18, 2005
- Bayer Pharmaceuticals Corporation
- Delanie Cassell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid and polypeptide sequences useful as adjuvants
- Patent number 6,752,995
- Issue date Jun 22, 2004
- Board of Regents, The University of Texas System
- Stephen A. Johnston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of parapox PP30 protein to modify immune responses to administe...
- Patent number 6,752,996
- Issue date Jun 22, 2004
- Board of Regents, The University of Texas System
- Stephen A. Johnston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of parapox B2L protein to modify immune responses to administer...
- Patent number 6,723,329
- Issue date Apr 20, 2004
- Board of Regents, The University of Texas System
- Stephen A. Johnston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vascular endothelial growth factor-like protein from orf viruses bi...
- Patent number 6,541,008
- Issue date Apr 1, 2003
- University of Otago
- Lyn M. Wise
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Parapoxviruses containing foreign DNA, their production and their u...
- Patent number 6,365,393
- Issue date Apr 2, 2002
- Bayer Aktiengesellschaft
- Norbert Schmeer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein
- Patent number 5,541,156
- Issue date Jul 30, 1996
- Mitsubishi Corporation
- Toshihiko Fukuhara
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
RECOMBINANT ORF VIRUS VECTOR
- Publication number 20220204992
- Publication date Jun 30, 2022
- Eberhard Karls Universität Tübingen Medizinische Fakultät
- Hanns-Joachim Rziha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ORF VIRUS VECTOR
- Publication number 20180148739
- Publication date May 31, 2018
- Eberhard Karls Universität Tübingen Medizinische Fakultät
- Hans-Joachim Rziha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...
- Publication number 20170320918
- Publication date Nov 9, 2017
- AiCuris GmbH & Co. KG
- Olaf WEBER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...
- Publication number 20140377297
- Publication date Dec 25, 2014
- Olaf WEBER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...
- Publication number 20130108704
- Publication date May 2, 2013
- AiCuris GmbH & Co. KG
- Olaf WEBER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Recombinant proteins of parapoxvirus ovis and pharmaceutical compos...
- Publication number 20040235721
- Publication date Nov 25, 2004
- Olaf Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Parapox B2L protein to modify immune responses to administer...
- Publication number 20040213807
- Publication date Oct 28, 2004
- Stephen A. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PARAPOX B2L PROTEIN TO MODIFY IMMUNE RESPONSES TO ADMINISTER...
- Publication number 20040054159
- Publication date Mar 18, 2004
- Stephen A. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vascular endothelial growth factor-like protein from ORF viruses bi...
- Publication number 20030211101
- Publication date Nov 13, 2003
- Lyn M. Wise
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic acid and polypeptide sequences useful as adjuvants
- Publication number 20030194695
- Publication date Oct 16, 2003
- Stephen A. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of parapox B2L protein to modify immune responses to administer...
- Publication number 20030194737
- Publication date Oct 16, 2003
- Stephen A. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Parapox B2L protein to treat cancer and modify immune responses
- Publication number 20030109483
- Publication date Jun 12, 2003
- Delanie Cassell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Recombinant Orf virus vector

Method of treatment using oncolytic viruses

Recombinant proteins of parapdxvirus ovis and pharmaceutical compos...

Recombinant proteins of Parapoxvirus ovis and pharmaceutical compos...

Recombinant proteins of parapoxvirus ovis and pharmaceutical compos...

Use of Parapox B2L protein to treat cancer and modify immune responses

Nucleic acid and polypeptide sequences useful as adjuvants

Use of parapox PP30 protein to modify immune responses to administe...

Use of parapox B2L protein to modify immune responses to administer...

Vascular endothelial growth factor-like protein from orf viruses bi...

Parapoxviruses containing foreign DNA, their production and their u...

Protein

Patents Applicationslast 30 patents

RECOMBINANT ORF VIRUS VECTOR

RECOMBINANT ORF VIRUS VECTOR

RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...

RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...

RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOS...

Recombinant proteins of parapoxvirus ovis and pharmaceutical compos...

Use of Parapox B2L protein to modify immune responses to administer...

USE OF PARAPOX B2L PROTEIN TO MODIFY IMMUNE RESPONSES TO ADMINISTER...

Vascular endothelial growth factor-like protein from ORF viruses bi...

Nucleic acid and polypeptide sequences useful as adjuvants

Use of parapox B2L protein to modify immune responses to administer...

Use of Parapox B2L protein to treat cancer and modify immune responses